1. Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition
    Lorena Avila-Carrasco et al, 2019, Frontiers in Pharmacology CrossRef
  2. The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition
    Asefeh Dahmardeh Ghalehno et al, 2022, Nutrition and Cancer CrossRef
  3. Polyphyllin D induces necroptosis in neuroblastoma cells (IMR-32 and LA-N-2) in mice
    Shunsuke Watanabe et al, 2023, Pediatric Surgery International CrossRef
  4. Polyphyllin I and VII potentiate the chemosensitivity of A549/DDP cells to cisplatin by enhancing apoptosis, reversing EMT and suppressing the CIP2A/AKT/mTOR signaling axis
    Feifei Feng et al, 2019, Oncology Letters CrossRef
  5. Natural Polyphyllins (I, II, D, VI, VII) Reverses Cancer Through Apoptosis, Autophagy, Mitophagy, Inflammation, and Necroptosis
    Bashir Ahmad et al, 2021, OncoTargets and Therapy CrossRef
  6. Exploring the Effect of Polyphyllin I on Hepatitis B Virus-related Liver Cancer through Network Pharmacology and in vitro Experiments
    Puhua Zeng et al, 2022, Combinatorial Chemistry & High Throughput Screening CrossRef
  7. Polyphyllins in cancer therapy: A systematic review and meta-analysis of animal studies
    Yan Bai et al, 2023, Phytomedicine CrossRef
  8. Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?
    Cong Chen et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
  9. The comparison analysis of polyphyllin I and its analogues induced apoptosis of colon and lung cancer cells via mitochondrial dysfunction
    Li‐Jiao You et al, 2021, Basic & Clinical Pharmacology & Toxicology CrossRef
  10. Melittin Inhibits Growth of Human Osteosarcoma 143B Cells through Induction of Apoptosis via Suppressing the Wnt/β-catenin Signaling Pathway
    Xiaoliang Xie et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  11. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts
    Ruizeng Dong et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  12. Chemical Constituents and Pharmacological Activities of Steroid Saponins Isolated from Rhizoma Paridis
    Fen Liu et al, 2021, Journal of Chemistry CrossRef
  13. Therapeutic effects on cancer of the active ingredients in rhizoma paridis
    Jie Li et al, 2023, Frontiers in Pharmacology CrossRef
  14. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway
    Qiong Wang et al, 2018, Frontiers in Immunology CrossRef
  15. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3β/β-Catenin Signaling Pathway
    Mianmian Liao et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  16. Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition
    Fei-Fei FENG et al, 2019, Chinese Journal of Natural Medicines CrossRef
  17. Disruption of Colorectal Cancer Network by Polyphyllins Reveals Pivotal Entities with Implications for Chemoimmunotherapy
    Ram Siripuram et al, 2022, Biomedicines CrossRef
  18. Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation
    Feifei Feng et al, 2023, Biotechnology and Genetic Engineering Reviews CrossRef
  19. Polyphyllin I suppressed the apoptosis of intervertebral disc nucleus pulposus cells induced by IL-1β by miR-503-5p/Bcl-2 axis
    Lei Yuan et al, 2023, Journal of Orthopaedic Surgery and Research CrossRef
  20. Mycorrhizas Affect Polyphyllin Accumulation of Paris polyphylla var. yunnanensis through Promoting PpSE Expression
    Hailing Li et al, 2021, Phyton CrossRef
  21. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition
    Wei Lou et al, 2017, Biological & Pharmaceutical Bulletin CrossRef